Waystar plans to acquire AI-driven revenue cycle management company Iodine Software, its first acquisition since going public last year. Waystar, a healthcare payment software maker, announced a definitive agreement to acquire Iodine Software from shareholders led by Advent International, a global private equity investor, for a total enterprise value of $1.25 billion. The deal would add Iodine Software’s clinical intelligence capabilities to Waystar’s software. The company developed AI-powered software solutions to address automation for clinical administration and revenue cycle management. Iodine’s technology uses proprietary AI models trained on one of the industry’s largest clinical datasets, representing more than a third of all U.S. inpatient discharges, according to the company.
Read the full article: Waystar to Buy Iodine Software for $1.25B to Boost AI-Enabled Revenue Cycle Management //
Source: https://www.fiercehealthcare.com/health-tech/waystar-buy-iodine-software-125b-boost-ai-enabled-revenue-cycle-management